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SI Materials and Methods
Yeast Strains, Media, and Genetic Techniques. The S. cerevisiae
strains used in this work are described in Table S1. Standard
techniques (1) were used for strain construction and transfor-
mation. The strains CHY107, CHY108, CHY115, CHY116, and
CHY169 were produced by extending the endogenous MGT1
ORF in the S. cerevisiae strains JD52, JD55, CHY49, or CHY50
(Table S1) with a sequence encoding 13 head-to-tail repeats of
the myc epitope tag (1). This was done using a PCR-mediated
gene targeting that used pFA6a-13MYC-TRP1 (2), similarly to
a previously described procedure that was used for gene disrup-
tion (3). S. cerevisiae CHY121, CHY122, CHY169, CHY194,
CHY195, and CHY219 were constructed through disruptions of
MGT1 or UFD4 in JD52, JD55, and CHY108 strains (Table S1),
using a PCR-mediated gene disruption that used pFA6a-
KanMX6 or pFA6a-TRP1 (2) similarly to a previously described
procedure (3). S. cerevisiae that were null mutants in specific E2
or E3 genes were either from the Varshavsky laboratory’s strain
collection, or obtained from Dr. Youming Xie (Wayne State
University, Detroit, MI), or purchased fromOpen Biosystems. S.
cerevisiae media included YPD (1% yeast extract, 2% peptone,
2% glucose; only most relevant media components are cited); SD
medium (0.17% yeast nitrogen base, 0.5% ammonium sulfate,
2% glucose); and synthetic complete (SC) medium (0.17% yeast
nitrogen base, 0.5% ammonium sulfate, 2% glucose, plus a
drop-out mixture of compounds required by a given auxotrophic
strain).
Plasmids and Site-Directed Mutagenesis. The plasmids used in this
study are cited in Table S2. The low copy (CEN-based) pCH336
plasmid expressed Mgt1f3 (C-terminally tagged with flag3) from
the native PMGT1 promoter. To construct pCH336, the promoter
region and the MGT1 ORF were PCR-amplified from S. cerevi-
siae genomic DNA using OCH576/OCH450 and OCH492/
OCH577 primers (Table S3). The resulting DNA fragments was
digested with BamHI/HindIII and HindIII/XhoI, respectively,
and triply ligated into BamHI/XhoI-cut pRS416 (4). Overlap-
extension PCR (5) was used to introduce codons encoding Ser151
or Met151 instead of wild-type (WT) active-site Cys151 into the
ORF of MGT1. A pair of the above PCR primers (OCH576/
OCH577) was used, in conjunction with primers OCH540/
OCH541 or OCH553/OCH554 (Table S3), for the cloning of
pCH337or pCH338, respectively (Table S2). For example, to
construct pCH337, which expressed Mgt1C151S, two overlapping
DNA fragments with a requisite missense mutation were pro-
duced initially, using PCR with the primer pairs OCH576/
OCH541 and OCH540/OCH577 (Table S3). These fragments
were then denatured and reannealed, so that they formed a
partially duplex DNA that encompassed the site of mutation
contained 3 overhangs that enabled another PCR, with the
primers OCH576 and OCH577 (Table S3), that yielded both the
MGT1C151SORF and its promoter. DNA fragments produced by
this procedure (which encoded either Mgt1C151S or Mgt1C151M)
were digested with BamHI/XhoI and subcloned into BamHI/
XhoI-cut pRS416 vector, yielding, respectively, pCH337 and
pCH338 (Table S2). The ubiquitin (Ub) reference (UR) (6)
plasmids pCH280 and pCH281 were constructed by inserting the
SacII/EcoRI-digested, PCR-amplified MGT1 ORF (using the
primer pair OCH494/OCH495) into SacII/EcoRI-cut
pMET416FUPRCUP9NSF (7). To construct pCH285, which ex-
pressed GST-Mgt1-His10, the MGT1-His10 ORF, encoding also
the C-terminal His10 tag, was produced by PCR and the primer
pair OCH492/OCH498 (Table S3). The resulting DNA fragment
was cloned into BamHI/XhoI-cut pGEX-4T3 (GE Healthcare).
Construction details for other plasmids (Table S2) are available
upon request. All of the final plasmid constructs were verified by
DNA sequencing.
Preparation of Cell Extracts for Immunoblot Analysis. Yeast extracts
were prepared using a modification of Kushnirov’s method (8).
After yeast cells were grown to exponential phase in selective
medium, 1 mL of a culture with A600 of 1 was centrifuged for 30
sec at 11,200g. Cells were resuspended in 1 mL of 0.2 M NaOH,
and incubated for 20 min on ice or for 5 min at room temper-
ature, followed by centrifugation for 30 sec at 11,200g. The
pelleted cells were resuspended in 50L of HU buffer (8M urea,
5% SDS, 1 mM EDTA, 100 mM DTT, 0.005% bromophenol
blue, 0.2 M TrisHCl, pH 6.8) containing protease inhibitor
mixture (Sigma–Aldrich), and heated for 10 min at 70 °C. After
centrifugation for 5 min at 11,200g, 10 L of supernatant was
subjected to SDS/4–12% NuPAGE (Invitrogen) and immuno-
blotted with either anti-f lag (Stratagene), anti-myc, anti-ha, or
anti-tubulin antibodies (Sigma–Aldrich).
In vivo Mgt1 polyubiquitylation assays (Fig. 2B and the main
text) used the plasmids pUB204 (UbK48R,G76A), pUB223 (His6-
UbK48R,G76A), and pCH277 (Mgt1ha) (Table S2). S. cerevisiae
expressing Mgt1ha and overexpressing either UbK48R,G76A (lane
1) or His6-UbK48R,G76A (lane 2) were grown to A600 of0.5 in SD
medium with required amino acids containing 0.2 mM CuSO4
(to induce the PCUP1 promoter) for 3 h before the addition of
MG132 to the final concentration of 50 M for 30 min, followed
by a further incubation in the presence of 68 MMNNG for 1 h.
Cell extracts were subjected to Ni-NTA chromatography under
denaturing conditions; the retained proteins were fractionated
by SDS/4–12% NuPAGE, followed by IB with anti-ha antibody
(Fig. 2C and the main text).
GST Fusions and Pulldown Assay, and Purification of GST-Mgt1-His10
from E. coli. The plasmid pCH285 (Table S2), which encoded
GST-Mgt1-His10, was transformed into the E. coli BL21-Codon
Plus (DE3)-RIL strain (Stratagene). A total of 50 mL of
overnight culture of transformed cells was inoculated into 1 L of
LB medium containing 0.1 mg/ml ampicilin and 34 g/ml
chloramphenicol, followed by growth at 37 °C for 1 h to A600
of0.8. The expression of GST-Mgt1-His10 was induced with 0.2
mM isopropyl -D-thiogalactoside (IPTG) at 30 °C for 4 h.
GST-Mgt1-His10, was purified from cell extracts by affinity
chromatography with Ni-NTA resin (Qiagen). Specifically, E.
coli cells were harvested by centrifugation and frozen at -80 °C.
Cell pellets were thawed and resuspended in the Ni-NTA binding
buffer (0.3 M NaCl, 10 mM imidazole, 10 mM -mercaptoetha-
nol, 50 mMNaH2PO4/Na2HPO4, pH 8.0) containing chicken egg
white lysozyme (1 mg/ml; Sigma–Aldrich). The cells were incu-
bated at 4 °C for 30 min and thereafter disrupted by sonication,
3 times for 1 min each at 1-min intervals, followed by the addition
of Nonidet P-40 to the final concentration of 0.1%. After
centrifugation at 11,200g for 30 min, the supernatant was added
to a 2-ml Ni-NTA resin (Qiagen, 50% slurry), and incubated for
1 h at 4 °C. The resin was transferred to a 10-mL column and
washed 4 times in 10 mL of washing buffer (0.5 M NaCl, 20 mM
imidazole, 10 mM -mercaptoethanol, 0.1% Nonidet P-40, 50
mM NaH2PO4/Na2HPO4, pH 8.0). GST-Mgt1-His10 was then
eluted with 1-mL samples of the binding buffer containing
increasing levels of imidazole (25, 50, 100, 150, 200, 250, 300
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mM), followed by overnight dialysis against storage buffer (10%
glycerol, 0.15 M NaCl, 10 mM -mercaptoethanol, 50 mM
Hepes, pH 7.5).
GST-pulldown assays with extracts from S. cerevisiae contain-
ing fUbr1 were carried out essentially as described in ref. 9, with
a slight modification. Either a GST-fusion protein or GST alone
(5 g) was incubated with 10 L GST-Sepharose (50% slurry)
in 50 L of 50 mM NaH2PO4/Na2HPO4 (pH 8.0) for 20 min on
ice. The beads were washed once with 0.5 mL of GST-loading
buffer (10% glycerol, 1% Nonidet P-40, 0.5 M NaCl, 1 mM
EDTA, 50 mM TrisHCl, pH 8.0) and once with 0.5 mL of
GST-binding buffer (10% glycerol, 0.05% Nonidet P-40, 50 mM
NaCl, 50mMHepes, pH 7.8). Samples of washed beads in 0.1 mL
of GST-binding buffer were incubated with 0.16-mL samples of
yeast extracts containing fUbr1 in the absence or presence of
indicated dipeptides, at 1 mM each. The beads were washed 3
times with 0.25 mL of GST-binding buffer containing dipeptides
at 1 mM, and the bound proteins were eluted by adding 12.5 L
of 2 SDS loading buffer and incubating the sample at 95 °C for
5 min, followed by SDS/4–12% NuPAGE and immunoblotting
with anti-f lag antibody.
Pulse–Chase Assays. Pulse–chase experiments were performed
essentially as described (7, 10), with slight modifications. S.
cerevisiae JD52 (WT), JD55 (ubr1), and CHY195 (ubr1
ufd4) (Table S1) that carried the plasmids pCH280, pCH437,
pCH438, or pCH439 (Table S2) were grown at 30 °C to A600 of
1 in 10 mL of SD medium with required amino acids. Cells
were pelleted by centrifugation and washed with 0.8 mL of the
medium. Cell pellets were gently resuspended in 0.4 mL of the
same medium and labeled for 5 or 10 min at 30 °C with 0.16 mCi
of 35S-EXPRESS (Perkin-Elmer). Cells were pelleted again and
resuspended in 0.4 mL of SD medium containing unlabeled
L-methionine (10 mM) and L-cysteine (5 mM), in addition to
required amino acids. Samples (0.1 mL) were taken at the
indicated time points, followed by preparation of extracts, im-
munoprecipitation with anti-f lag antibody cross-linked to aga-
rose beads (Sigma–Aldrich), SDS/4–12% NuPAGE in Mes
buffer, and autoradiography.
Mutation Frequency and Sensitivity of Cells to MNNG Treatment. To
measure increases in mutation rate that were caused by MNNG,
the JD52 (UBR1), JD55 (ubr1), CHY121 (mgt1) or CHY122
(mgt1 ubr1) S. cerevisiae were grown in YPD medium (from
200 cells per ml) for 2 days (38 h) to A600 of 5. The cells
in YPD were incubated in the absence or presence of 34 M
MNNG for 30 min at 30 °C. Cells in 1 mL of culture (A600 of5)
were pelleted by centrifugation, then washed once in 1 mL of
phosphate buffered saline (PBS), then pelleted again, and
resuspended in 1 mL of PBS. To determine the frequency of
mutations that conferred canavanine resistance, 0.1-mL samples
of cells were spread onto SC-Arg plates containing canavanine
(60 g/ml) and incubated for 3 days at 30 °C. To determine the
fraction of viable cells, these cell suspensions were diluted
250,000-fold in PBS, and 0.1-mL samples were spread on YPD
medium, followed by incubation for 3 days at 30 °C. To deter-
mine whether the C-terminal 13-myc epitope of Mgt1m13 affects
MNNG sensitivity of cells expressing Mgt1m13 instead of WT
Mgt1, the corresponding S. cerevisiae strains were grown to A600
of0.5 in YPDmedium, followed by the additionMNNG (to the
final concentration of 30 M) for 3 h. The cultures were 5-fold
serially diluted, spotted onto YPD medium, and incubated for 2
days at 30 °C. To determine the fraction of surviving cells after
treatments with MNNG, the YPH277 (UBR1) or YPH277 HR1
(ubr1) S. cerevisiae strains (Table S1) were grown in YPD
medium at 30 °C to A600 of 1. Stock MNNG solution (6.8 mM
in 50 mM Na-acetate, pH 5.0) was added to 1-ml cell suspen-
sions, to the indicated final concentrations of MNNG. Samples
were incubated with vigorous shaking for 1 h at 30 °C, followed
by appropriate dilutions in PBS, spreading on YPD plates,
incubation for 3 days at 30 °C, and measurements of colony
numbers.
In Vivo Ubiquitylation Assay. S. cerevisiae JD52 that expressed
Mgt1ha (from pCH279) and overexpressed either UbK48R,G76A
(from pUB204) or His6-UbK48R,G76A (from pUB223) were grown
at 30 °C to A600 of 0.4 in SC(-Trp, -Ura) medium. Cells were
then treated with 0.2 mM CuSO4 (to induce the expression of
His6-UbK48R,G76A) for 2.5 h at 30 °C, and thereafter with 68 M
MNNG for 1 h. Pelleted and washed cells were resuspended and
placed in the bead-beater in the denaturing lysis buffer [6 M
guanidine hydrochloride, 1 mM PMSF, 0.1 M NaH2PO4, 10 mM
N-ethylmaleimide, 20 mM TrisHCl (pH 8.0) and protease
inhibitor mixture]. The suspension was centrifuged at 11,200g for
20 min, and the supernatant was incubated with Ni-NTA agarose
beads (Qiagen) for 2 h at 4 °C. The beads were washed 4 times
in denaturing lysis buffer, followed by 4 times in wash buffer (0.5
M NaCl 50 mM Tris, pH 8.0). Bound proteins were eluted in
elution buffer (1% SDS, 0.1 M EDTA, 0.1 mMDTT, 0.1 M Tris,
pH 6.8) and fractionated by SDS/4–12% NuPAGE, followed by
immunoblotting with anti-ha antibody (Sigma–Aldrich).
Expression and Purification of Ufd4, Ubr1, Rad6 and Ubc4. The S.
cerevisiae JD52 (Table S1) that carried p314CUP1FlagUFD4
(Table S2) and expressed the N-terminally f lag-tagged Ufd4
(fUfd4) was grown at 30 °C to A600 of 4 in 4-L of SC(-Trp)
medium containing 0.2 mM CuSO4. The cells were harvested by
centrifugation, washed once with PBS, and frozen in liquid N2.
Cells in a frozen pellet (20 g) were broken using glass beads for
5  40 sec at the power setting of 6.5 in FastPrep-24 (MP
Biomedicals) in 40 mL of lysis buffer (10% glycerol, 0.5%
Nonidet P-40, 0.2 M KCl, 1 mM PMSF, 5 mM -glycerol
phosphate, 50 mMHepes, pH 7.5) containing protease inhibitor
mixture ‘‘for use with fungal and yeast extracts’’ (Sigma–Aldrich).
The suspension was centrifuged at 11,200g for 30 min, and the
supernatant was mixed with 2 mL of anti-f lag M2 affinity beads
(Sigma–Aldrich) at 4 °C for 1 h. The beads were collected by
centrifugation in Sorvall RT-600B at 1,000 rpm for 5 min at 4 °C,
and were washed, sequentially, with 10 mL of lysis buffer, 10 mL
of buffer A [10% glycerol, 0.5% Nonidet P-40, 1 M KCl, 1 mM
EDTA, 50 mM Hepes (pH 7.5), 5 mM -mercaptoethanol], and
10 mL of buffer B (lysis buffer without Nonidet P-40). fUfd4 that
was bound by the anti-f lag antibody was eluted from the beads
with buffer C (buffer B containing flag peptide at 0.5 mg/ml),
and thereafter dialyzed at 4 °C overnight against dialysis buffer
(10% glycerol, 0.15 M NaCl, 5 mM -mercaptoethanol, 50 mM
Hepes, pH 7.5).
N-terminally f lag-tagged Ubr1 (fUbr1) was overexpressed in
S. cerevisiae SC295 (Table S1) and purified by fractionation over
anti-f lag M2 antibody agarose resin as described in ref. 3. S.
cerevisiae Rad6 or Ubc4 were overexpressed in the E. coli
BL21-Codon Plus (DE3)-RIL strain and purified as described
previously (7, 9).
In Vitro Ubiquitylation Assay. Purified S. cerevisiae Uba1(Ub-
activating enzyme, E1) and human Ub were from Boston
Biochem. S35-labeled Mgt1f3 was expressed in the reticulocyte-
based in vitro transcription/translation TNT T7 Quick for PCR
DNA kit (Promega), using a PCR-derived DNA fragment that
was produced with pCH437 (Table S2) as a template and the
primer pair OCH834/OCH438 (Table S3). A total of 2 1 of
35S-labeled Mgt1 was incubated with purified fUbr1 (0.2 M),
fUfd4 (0.2 M), Rad6 (1 M), and/or Ubc4 (1 M) (see Fig. 4)
at 30 °C for 15min in 20L of reaction samples (4 mMATP, 0.15
M NaCl, 5 mM MgCl2, 1 mM DTT, 50 mM Hepes, pH 7.5)
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containing 100 nM Uba1 and 80 M Ub. The reactions were
terminated by adding 8 L of 4  SDS/PAGE loading buffer.
Samples of 14 L were heated at 95 °C for 5 min, followed by
SDS/4–12% NuPAGE in Mops buffer, and autoradiography.
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Fig. S1. (A) ‘‘Chases’’ with cycloheximide to test putative Ubr1-interacting proteins for their degradation by the N-end rule pathway in vivo. The S. cerevisiae
proteins examined in these experiments were described as proteins that could be coimmunoprecipitatedwith S. cerevisiaeUbr1 in proteomic-scale experiments
(1–3). JD52 (WT) and JD55 (ubr1) S. cerevisiae carrying plasmids (Table S2) that expressed the indicated proteins were grown at 30 °C to A600 of1.0, followed
by a ‘‘chase’’ with cycloheximide for 1 and 2 h, as described in SI Materials andMethods, using immunoblotting with anti-ha and anti-myc antibodies. Note that
although most of the tested proteins were apparently short-lived in vivo, only Mgt1 was significantly stabilized in the absence of Ubr1. (B) Accumulation of
ubiquitylated Mgt1m13 (Mgt1myc13) in the presence of MG132, a proteasome inhibitor. MG132-sensitive pdr5 S. cerevisiae (4) CHY115 cells (MGT1myc13::TRP1
pdr5::KanMX6) (Table S1)weregrown toA600of1and incubated further in thepresenceof eitherMG132 (50M)ordimethyl sulfoxide (anequivalent amount
of solvent of the stock solution ofMG132) for indicated times at 30 °C. Cell extracts were fractionated by SDS/4–12%NuPAGE and immunoblottedwith anti-myc
and anti-tubulin antibodies. The (overexposed) band of full-length Mgt1m13 and its ubiquitylated derivatives are denoted on the right. Overexposure was used
to facilitate the detection of ubiquitylated Mgt1m13. An asterisk denotes a (presumed) proteolytic fragment of Mgt1m13. (C) WTMGT1was replaced by an ORF
encodingMgt1m13, a derivative C-terminally taggedwith themyc13 epitope and expressed from the native PMGT1 promoter. Mgt1m13 was indistinguishable from
WTMgt1 in its ability to protect cells fromMNNG.WTorubr1 strains expressing eitherWTMgt1orMgt1m13, and a congenicWT strain lackingMgt1weregrown
toA600 of0.5 inYPDmediumand further growneither in thepresenceor absenceof 30MMNNGfor 3h in the samemedium. The cultureswere serially diluted
5-fold, spotted on YPD plates, and incubated for 2 days at 30 °C. (D) The Rad6 E2 enzyme is required for Mgt1 degradation. A set of S. cerevisiae null mutants
in genes encoding specific E2 (Ub-conjugating) enzymes carried pCH336, which expressed Mgt1f3 from the PMGT1 promoter. Cells were grown to A600 of0.8 at
30 °C, and thereafter incubated at 37 °C for 1 h (to increase the assay’s sensitivity; see the main text), followed by a ‘‘chase’’ with cycloheximide (50 g/ml) for
30min. Cell extractswere fractionatedby SDS/4–12%NuPAGE, followedby IBwith anti-flagandanti-tubulin antibodies. (E) Heat-induceddegradationofMgt1f3
is apparently independent of the identity of its residue at position 151. The same strains and procedures as in A, except that cells were not treated with MNNG,
and were incubated, instead, at 37 °C for 1 h, followed by a ‘‘chase’’ with cycloheximide, also at 37 °C.
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Fig. S2. (A) Pulse–chase analysis, using the Ub-reference (UR) technique, of flag-tagged Mgt1f3. JD52 (WT) cells (lanes 1–3) and JD55 (ubr1) cells (lanes 4–6)
expressing fDHFR-UbK48R-Mgt1f (pCH281) were grown at 30 °C to A600 of 1, followed by labeling for 5 min with [35S]methionine/cysteine and a chase (in the
presence of cycloheximide) for 0, 10 or 30 min at 30 °C. Cell extracts were precipitated with anti-flag antibody, followed by SDS/4–12% NuPAGE and
autoradiography. ‘‘Reference’’ on the left denotes the fDHFR-UbK48R moiety. (B) Cycloheximide ‘‘chase’’ assays with JD52 (WT), JD55 (ubr1), or double-mutant
CHY134 (ubr1 ubr2) S. cerevisiae strains expressing Mgt1f3. (C) WT S. cerevisiae expressing Mgt1m13 (Mgt1myc13) from the PMGT1 promoter were grown to A600
of0.6, and thereafter preincubated for 1 h at 30 °C (lanes 1–3), or at 37 °C (lanes 4–6), or at 30 °C but in the presence of 1 mMH2O2 (lanes 7–9), with the same
(preincubation) conditionsduring cycloheximide ‘‘chases’’ for 20and40min. Cell extractswere fractionatedby SDS/4–12%NuPAGE, followedby IBwithanti-myc
and anti-tubulin antibodies. (D) Ubr1-lacking S. cerevisiae are more resistant toMNNG-inducedmutagenesis. JD52 (WT) (filled bar) and JD55 (ubr1) (open bar)
S. cerevisiaewere seeded in YPDmedium at200 cell/ml, and grown for38 h to A600 of5. Cell suspensions were incubated in the presence of 34 MMNNG
for 30 min at 30 °C, then diluted with PBS and spread onto either YPD plates or arginine-lacking SC(-Arg) plates containing canavanine (60 g/ml), to select for
canavanine-resistant cells. Plates were incubated for 3 days at 30 °C, and the resulting colonies were counted. (E) Cells of indicated genotypes (Table S1) were
grown to A600 of0.6 in YPD medium at 30 °C, and were further incubated in the presence of 0.1 mMMNNG for 1 h. The cultures were serially diluted 5-fold,
spotted on YPD plates, and incubated for 2 days at 30 °C. (F) WT, ubr1 and double-mutant ubr1 ufd4 S. cerevisiae that expressed chromosomally integrated
MGT1m13 (see SI Materials and Methods) were grown at 30 °C to A600 of 0.8, and were further incubated for 1 h at 37 °C, followed by a ‘‘chase’’ with
cycloheximide, also at 37 °C. SDS/4–12% NuPAGE of cell extracts was followed by IB with anti-myc and anti-tubulin antibodies. (G and H) WT and ufd4 S.
cerevisiaewith chromosomally integratedMGT1m13 (see SIMaterials andMethods)were grown in SCmediumat 30 °C toA600 of0.8 andwere further incubated
in the presence of MNNG (68 M) for 1 h (panel G), or at 37 °C (panel H), followed by a ‘‘chase’’ with cycloheximide for 10, 20, and 40 min, fractionation of cell
extracts by SDS/4–12% NuPAGE, and IB with anti-myc and anti-tubulin antibodies.
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Fig. S3. (A) Four putative -sheets in the N-terminal region of S. cerevisiae Mgt1 that are sequelogous (similar in sequence), and probably also spalogous
(spatially similar) (1) to the corresponding regions of human Mgmt (MGMT), the structure of which was determined previously (2). Residues identical between
S. cerevisiae Mgt1 and human MGMT are in bold. (B) The structure of human Mgmt and a model of its interaction with DNA (2). Alkyl lesions are removed by
Mgt1 and Mgmt from DNA through a base-flipping mechanism (3). (C) The hypothetical 3D structure of S. cerevisiae Mgt1, produced by Modeller-9v1
(http://salilab.org/modeller/), using the structure of human Mgmt (1eh6.pdb) as its template, and displayed using PyMol (DeLano Scientific). (D) Sequence
alignments amongO6-alkyguanine transferases of the yeasts (fungi) S. cerevisiae (Sc) and Kluyveromyces lactis (Kl), the prokaryote E. coli (Ec), and themammals
Homo sapiens (Hs) and Mus musculus (Mm).
1. Varshavsky A (2004) Spalog and sequelog: Neutral terms for spatial and sequence similarity. Curr Biol 14:R181–R183.
2. Wibley JEA, Pegg AE, Moody PCE (2000) Crystal structure of the human O6-alkylguanine-DNA alkyltransferase. Nucl Acids Res 28:393–401.
3. Daniels DS, et al. (2004) DNA binding and nucleotide flipping by the human DNA repair protein AGT. Nat Struct Mol Biol 11:714–720.
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Fig. S4. (A) JD52 (WT) and JD55 (ubr1)
S. cerevisiae expressing either full-length
Mgt1f3 (from the PMGT1 promoter on a low
copy plasmid) or its C-terminally truncated
derivatives were grown to A600 of 0.8,
followedby SDS/4–12%NuPAGEof cell ex-
tractsand IBwithanti-flagandanti-tubulin
antibodies. Lanes 1 and 2, full-length
Mgt11–188,f3 in WT and ubr1 cells, respec-
tively. Lanes 3 and 4, same as lanes 1 and 2,
respectively, but with Mgt11–144,f3. Lanes 5
and 6, same but with Mgt11–100,f3. Lanes 7
and 8, same but with Mgt184–188,f3. (B)
Equal amounts of extracts (50 g) from S.
cerevisiae that expressed the N-terminally
flag-tagged Ubr1 (fUbr1) were incubated
ineither thepresenceorabsenceof specific
dipeptides (eachofthemat1mM)withGST
alone or specific GST fusions (5 g) that
were linked to glutathione-Sepharose
beads. Bound proteins were eluted from
the beads and fractionated by SDS/4–12%
NuPAGE, followed by IB with anti-flag an-
tibody. Lane 1, 2.5% of the initial (total)
input of fUbr1. Lane 2, GST alone. Lane 3,
GST-Mgt1. Lane 4, same as lane 3 but with
Arg-Ala (R-A, 1mM). Lane5, sameas lane 4
butwithAla-Arg (A-R, 1mM). Lane6, same
as lane3butwithLeu-Ala (L-A,1mM).Lane
7, same as lane 3 but with Ala-Leu (A-L, 1
mM). Lane 8, same as lane 3 but with both
Arg-Ala and Leu-Ala (R-A and L-A, 1 mM
each). Lane 9, same as lane 3 butwith both
Ala-Arg andAla-Leu (A-R,A-L, 1mMeach).
Lane 10, GST-Rad6. Lane 11, GST-Cup9.
Lane 12, same as lane 11 but with both
Arg-Ala and Leu-Ala (R-A and L-A, 1 mM
each). (C) Equal amounts of extracts (0.2
mg) from S. cerevisiae that expressed the
N-terminally ha-tagged Ufd4 (haUfd4)
were incubated with GST alone or specific
GST fusions (5g), andwereprocessedas
described in B, except that IB that haUfd4
was detected by was performed with an-
ti-ha antibody. Lane 1, 1% of the initial
(total) input of haUfd4. Lane 2, GST-Mgt1.
Lane 3, same as lane 2 but with Arg-Ala
(R-A,1mM).Lane4, sameas lane2butwith
Ala-Arg (A-R, 1mM). Lane5, sameas lane 2
butwith Leu-Ala (L-A, 1mM). Lane 6, same
as lane2butwithAla-Leu(A-L,1mM).Lane
7, sameas lane2butwithbothArg-Alaand
Leu-Ala (R-A and L-A 1 mM each). Lane 8,
same as lane 2 but with both Ala-Arg and
Ala-Leu (A-R and A-L, 1 mM each). Lane 9,
GSTalone. (D)Mgt1 interactswithUfd4.Extracts (1mg) fromS. cerevisiae cells coexpressinghaUfd4 (fromthepRS313CUP1haUFD4plasmid;TableS2)andeitheravector
aloneorMgt1f3 (fromtheplasmidpCH437)wereprecipitatedwithanti-flagantibody,usingproteinGlinkedtomagneticbeads. Immunoprecipitateswerefractionated
by SDS/4–12% NuPAGE, followed by IB with anti-ha and anti-flag antibodies. Lane 1, input sample (0.25% of extract used in immunoprecipitation assays) from cells
expressing haUfd4 and the (‘‘empty’’) vector p416MET25. Lane 2, same as lane 1 but from cells coexpressing haUfd4 andMgt1f3. Lane 3, haUfd4, immunoprecipitation
withanti-flagantibody in theabsenceof coexpressedMgt13f. Lane4, sameas lane3but haUfd4was coexpressedwithMgt1f3. Thebanddetected in lane3withanti-flag
antibody and marked by an arrow and asterisk, just below the position of Mgt1f3 (see lane 4), is the light chain of anti-flag antibody that was used for
immunoprecipitation aswell (see above). Because of light-chain’s abundance at that position on the IBmembrane, this otherwiseweak cross-reactionwas detectable
at the level of IB exposure shown (compare the level of the cross-reacting bandwith the levels of immunoprecipitatedMgt1 in lane 4). (E) Cup9-regulated circuits do
not influence theUbr1-mediateddegradationofMgt1.AVY16 (WT), AVY4 (ubr1), AVY50 (cup9), orAVY51 (ubr1 cup9) S. cerevisiae (Table S2) expressingMgt1f3
from the PMGT1 promoter on a low copy plasmidwere grown toA600 of0.8 in SC(-Ura)mediumat 30 °C, then incubated further at 37 °C for 1 h, followedby a 30-min
‘‘chase’’ with cycloheximide (at 50 g/ml), fractionation of cell extracts by SDS/4–12% NuPAGE and IB with anti-flag and anti-tubulin antibodies. Note that Mgt1f3
remained short-lived in cup9 cells (lanes 5, 6). (F) JD52 (WT), JD55 (ubr1), CHY194 (ufd4), or CHY195 (ubr1 ufd4) S. cerevisiae (Table S1) were grown to A600 of
0.6, and treatedwithMNNG (170M) for 1.5 h at 30 °C. The resulting cultures were serially diluted 5-fold, spotted on YPD plates, and incubated for 2 days at 30 °C.
Seealsothemain-textFig.3H. (G)Adouble-mutantubr1ufd4 strainofS. cerevisiae ishypersensitive tooverexpressionofMgt1. JD52(WT)andCHY195(ubr1ufd4)
cells carrying a vector alone (pRS426MET25), or expressing eitherMgt1f3 (pCH440), orMgt1C151S,f3 (pCH441), orMgt1C151M,f3 (pCH442)were grown in SDmedium (with
essential amino acids) to A600 of0.8, serially diluted, and spotted on SDmedium for 2 days at 30 °C. (H) Same as in C but single-colony growth assays with JD52 (WT)
and CHY195 (ubr1 ufd4) cells carrying either a vector alone or expressing Mgt1f3 from the PMET25 promoter on a high copy plasmid.
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Table S1. Some of the S. cerevisiae strains used in this study
Strains Genotypes and characteristics Source or ref.
JD52 MATa trp1- 63 ura3–52 his3- 200 leu2–3112. lys2–801 1
JD55 ubr1::HIS3 in JD52 1
SC295 MATa ura3–52 leu2–3,112 regl-501 gal1 pep4–3 2
AVY4 ubr1::LEU2 in JD52 Laboratory collection
AVY16 leu2–3,112::LEU2 in JD52 Laboratory collection
AVY50 cup9::LEU2 in JD52 Laboratory collection
AVY51 cup9::LEU2 in JD55 Laboratory collection
AVY105 ubr2::HIS3 in JD52 Laboratory collection
CHY49 pdr5::KanMX6 in JD52 3
CHY50 pdr5::KanMX6 in JD55 3
CHY92 GAL80::3HA::KanMX6 in JD52 This study
CHY93 GAL80::3HA::KanMX6 in JD52 This study
CHY94 KnaMX6::PGAL1::3HA-SRS2 This study
CHY95 KnaMX6::PGAL1::3HA-SRS2 This study
CHY101 SGS1::13MYC::TRP1 in JD52 This study
CHY102 SGS::13MYC::TRP1 in JD55 This study
CHY107 MGT1::13MYC::TRP1 in JD52 This study
CHY108 MGT1::13MYC::TRP1 in JD55 This study
CHY109 CCR4::3HA::TRP1 in JD52 This study
CHY110 CCR4::3HA::TRP1 in JD55 This study
CHY115 MGT1::13MYC::TRP1 pdr5::KanMX6 in JD52 This study
CHY116 MGT1::13MYC::TRP1 pdr5::KanMX6 in JD55 This study
CHY121 mgt1::KanMX6 in JD52 This study
CHY122 mgt1::KanMX6 in JD55 This study
CHY134 ubr1::LEU2 ubr2::HIS3 in JD52 This study
CHY161 PEX7::3HA in JD52 This study
CHY162 PEX7::3HA::TRP1 in JD55 This study
CHY163 YGL081W::13MYC::TRP1 in JD52 This study
CHY164 YGL081W::13MYC::TRP1 in JD55 This study
CHY169 MGT1::13MYC::TRP1 ufd4::KanMX6 in JD55 This study
CHY107 MGT1::13MYC::TRP1 in JD52 This study
CHY108 MGT1::13MCY::TRP1 in JD55 This study
CHY194 ufd4::KanMX6 in JD52 This study
CHY195 ubr1::HIS3 ufd4::KanMX6 in JD52 This study
CHY219 ufd4:: TRP1 MGT1–13MYC::KanMX6 in JD52 This study
YPH277 MATa ura3–52 ade2–101 trp1-D1 leu2-D1 CFVII (RAD2.d) URA3 SUP11 4
YPH277HR1 ubr1::LEU2 in YPH277 5
BY4425 ubc2:: KanMX4 in BY4741 Open Biosystems
BY3216 ubc4:: KanMX4 in BY4741 Open Biosystems
BY3994 ubc5::KanMX4 in BY4741 Open Biosystems
BBY67.3 ubc6::HIS3 in JD52 Laboratory collection
BY597 ubc7::KanMX4 in BY4741 Open Biosystems
BY6577 ubc8:: KanMX4 in BY4741 Open Biosystems
BY4763 ubc10:: KanMX4 in BY4741 Open Biosystems
BY1636 ubc11:: KanMX4 in BY4741 Open Biosystems
BY5214 ubc12:: KanMX4 in BY4741 Open Biosystems
BY4027 ubc13:: KanMX4 in BY4741 Open Biosystems
BY4454 mms2:: KanMX4 in BY4741 Open Biosystems
BY3771 bre1:: KanMX4 in BY4741 Open Biosystems
BY6430 rad5:: KanMX4 in BY4741 Open Biosystems
BY5787 rad18:: KanMX4 in BY4741 Open Biosystems
BY4425 ufd2:: KanMX4 in BY4741 Open Biosystems
BY3216 ufd4:: KanMX4 in BY4741 Open Biosystems
BY3994 hul4::KanMX4 in BY4741 Open Biosystems
BY597 hul5::KanMX4 in BY4741 Open Biosystems
BY6577 tom1:: KanMX4 in BY4741 Open Biosystems
BY4763 hrd1:: KanMX4 in BY4741 Open Biosystems
BY4156 hrd3:: KanMX4 in BY4741 Open Biosystems
BY4883 tul1:: KanMX4 in BY4741 Open Biosystems
BY7299 doa10::KanMX4 in BY4741 Open Biosystems
BY4814 ubr1:: KanMX4 in BY4741 Open Biosystems
BY1579 ubr2:: KanMX4 in BY4741 Open Biosystems
BY3771 bre1:: KanMX4 in BY4741 Open Biosystems
BY6430 rad5:: KanMX4 in BY4741 Open Biosystems
BY5787 rad18:: KanMX4 in BY4741 Open Biosystems
MGG15 ura3–52 cdc34–2 6
FW1808 MAT his4–912 R5 lys2–128 ura3–52 rps5–1 7
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Table S2. Some of the plasmids used in this study
Plasmids Characteristics Source or ref.
pFlagUBR1SBX fUbr1 in YEplac181, with PADH1 promoter 1
pMET416FUPRCUP9NSF fDHFR-UbK48R-Cup9NSF in pRS416MET25 2
P313CUPHaUFD4 pRS313CUP1-haUFD4 3
p314CUP1FlagUFD4 pRS314CUP1-fUFD4 Laboratory collection
pUB203 pRS424CUP1-UBIK48R,G76A Laboratory collection
pUB223 pRS424CUP1-His6-MYC-UBIK48R,G76A Laboratory collection
pCH100 pRS315-UBR1 4
pCH159 pRS315-UBR1C1220S 4
pCH279 pRS416MET25-MGT1ha This study
pCH280 pRS416MET25-fDHFR-UbK48R-MGT1f This study
pCH281 pRS426MET25-fDHFR-UbK48R-MGT1f This study
pCH285 pGEX4T-3-MGT1his10 This study
pCH336 pRS416-MGT13f This study
pCH337 pRS416-MGT1C151S,3f This study
pCH338 pRS416-MGT1C151M,3f This study
pCH371 pRS416-MGT184–188,3f This study
pCH372 pRS416-MGT11–100,3f This study
pCH374 pRS416-MGT11–144,3f This study
pCH437 pRS416MET25-MGT13f This study
pCH438 pRS416MET25-MGT1C151S,3f This study
pCH439 pRS416MET25-MGT1C151M,3f This study
pCH440 pRS426MET25-MGT13f This study
pCH441 pRS426MET25-MGT1C151S,3f This study
pCH442 pRS426MET25-MGT1C151M,3f This study
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Table S3. Some of the PCR primers used in this study
Name Sequence
OCH450 AAGATTACCAACGCCAGCCATATT
OCH492 ACAGGATCCATGAAGGAACTGCTTTACTATACA
OCH494 GATCCCGCGGTGGT ATGAAGGAACTGCTTTACTATACA
OCH495 AACGAATTCTTACTTGTCATCATCGTCCTTGTAGTCGGAAGTACCAGACAATCTACTAAGGCTTAAGCTATT
OCH498 AAACTCGAGCTAGTGATGATGGTGATGATGGTGATGGTGATGAGAACCTCTCAATCTACTAAGGCTTAAGCTATT
OCH540 AACCTGGCATTGTTAGTACCTTCTCATAGAATCGTTGGTAGCAAT
OCH541 ATTGCTACCAACGAT TCTATGAGAAGGTACTAACAATGCCAGGTT
OCH553 AACCTGGCATTGTTAGTACCTATGCATAGAATCGTTGGTAGCAAT
OCH554 ATTGCTACCAACGAT TCTATGCATAGGTACTAACAATGCCAGGTT
OCH576 AAC GGATCC CCTATAGAAA CCCGTGACGA AAGG
OCH577 AAACTCGAGTTACTTGTCATCGTCATCCTTGTAATCGATATCATGATCTTTATAATCACCGTCATGGTCTTTATAGTCACTAGTCAATCTACTAAGGCTTAAGCTATT
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